SEARCH:      Monitor Keywords |  Custom RSS

Organic compounds -- part of the class 532-570 series September class, title,number 09/11

20110237791 - 2-pyridone compounds: P

20110237792 - Quinoline derivatives and their use as 5-ht6 ligands:

20110230657 - Process for preparing quetiapine fumarate-toluene-water: The present invention relates to an improved process for preparing Quetiapine fumarate of formula (I).... Agent: Alembic Limited

20110224425 - Process for producing carbapenem derivative and intermediate crystal therefor: An object of the present invention is to provide a carbapenem synthetic intermediate which is advantageous in an industrial process. There are provided a process for producing Compound (I), or a pharmaceutically acceptable salt, or a solvate, or a crystal thereof, comprising reacting Compound (III) and Compound (IV) in the... Agent:

20110224426 - Process for the preparation of carbapenem compounds: The present invention relates to a process for the preparation of carbapenem compound of Formula (I), wherein P1 is hydrogen or a carboxyl protecting group, P3 is hydrogen or a hydroxyl protecting group, R1 is C1-3 alkyl, and A is selected from a group consisting of a) Formula (II), b)... Agent:

20110224427 - Systems for carbon dioxide and sulfur dioxide removal: This invention relates to sulfur based compounds useful in methods of carbon dioxide or sulfur dioxide removal.... Agent: E. I. Du Pont De Nemours And Company

20110224428 - Washing of an organic phase comprising caprolactam: The invention relates to a process for extracting an impurity from an organic phase comprising caprolactam, comprising extracting the impurity by washing said organic phase as a discontinuous phase with an aqueous phase as a continuous phase, the ratio of the flow of the aqueous phase in m3/hr, to the... Agent:

20110218338 - 2-aminopyrimidine modulators of the histamine h4 receptor: 2-Aminopyrimidine compounds are described, which are useful as H4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritus.... Agent: Janseen Pharmaceutiacal Nv

20110213142 - Method for producing biological heme iron, and iron supplementing composition containing the heme iron produced by same: The present invention relates to a method for biologically producing heme-iron through microorganism cultivation, and to an iron supplementing composition containing the heme-iron produced by the same. The present invention provides a method for biologically producing heme-iron through microorganism cultivation, making it possible to economically produce heme-iron or heme-iron preparations... Agent: Catholic University Industry Academic Cooperation Foundation

20110213143 - Compound having tafia inhibitory activity: e

20110213144 - Dye, photoelectric conversion element using the same, photoelectrochemical cell, and method of producing dye: wherein A represents a group of atoms necessary for forming a ring together with the carbon-nitrogen bond; at least one of Y1A and Y2A represents an acidic group, in which when they each represent an acidic group, they may be the same as or different from each other, or when... Agent: Fujifilm Corporation

20110213145 - Compounds and methods for inhibiting the interaction of bcl proteins with binding partners: The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.... Agent: Infinity Discovery, Inc.